High-dose recombinant interleukin-2/verapamil combination in advanced cancer.
Tagliaferri
P
P
Correale
P
P
Mottola
M
M
de Simone
G
G
Montesarchio
V
V
Matano
E
E
Rea
A
A
Morabito
A
A
Famiani
M
M
Ciardiello
F
F
Tortora
G
G
Caraglia
M
M
Barile
C
C
Palmieri
G
G
Bianco
A R
AR
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D007376:Interleukin-2; D011994:Recombinant Proteins; D014700:Verapamil